Coya Therapeutics Inc.

NASDAQ: COYA · Real-Time Price · USD
6.09
0.41 (7.12%)
At close: Aug 15, 2025, 3:59 PM
6.20
1.81%
After-hours: Aug 15, 2025, 07:54 PM EDT

Coya Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021
Cash & Equivalents
29.76B 35.53M 38.34M 31.06M 36.58M 35.99M 32.63M 10.89M 13.1M 16.32M 5.93M 8.65M 10.39M -4.34M 4.34M
Short-Term Investments
n/a n/a 38.3B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 8.68M n/a
Long-Term Investments
n/a n/a n/a n/a n/a 149.25K 11.25K n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.12M 258.25K n/a -4.34M 87.18K
Receivables
n/a n/a 730.58K n/a n/a n/a 7.5M n/a n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
3.67B n/a n/a n/a n/a n/a n/a 936.35K 1.29M 1.01M 1.25M n/a n/a n/a n/a
Total Current Assets
33.43B 38.37M 44.31M 35.51M 39.89M 37.33M 41.2M 11.82M 14.39M 17.33M 7.18M 8.71M 10.51M 4.34M 4.58M
Property-Plant & Equipment
24.91M 31.75K 38.59K 45.43K 52.27K 59.11K 65.95K 72.79K 79.63K 86.47K 93.31K 100.15K 112.61K n/a 120.67K
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
24.91M 31.75K 38.59K 45.43K 52.27K 208.36K 77.2K 72.79K 79.63K 86.47K 1.21M 358.4K 112.61K -4.34M 207.85K
Total Assets
33.45B 38.4M 44.35M 35.55M 39.94M 37.54M 41.27M 11.9M 14.47M 17.42M 8.4M 9.06M 10.63M n/a 4.79M
Account Payables
931.34K 1.69M 1.59M 336.72K 1.88M 1.59M 1.16M 633.95K 237.58K 541.75K 1.82M 1.31M 1.26M n/a 857.57K
Deferred Revenue
731.08K 841.41K 848.29K 573.09K 939.03K 689.67K 923.11K n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
4.5B n/a n/a n/a n/a 723.85K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Current Liabilities
4.5B 4.34M 3.82M 2.32M 3.83M 4.32M 5.05M 1.81M 1.22M 1.27M 3.82M 2.58M 1.59M n/a 1.15M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 12.97M 11.85M 10.45M n/a n/a
Other Long-Term Liabilities
641.16M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
641.16M 694.43K 945.45K 1.22M 856.65K 681.29K 574.68K n/a n/a 541.75K 12.97M 11.85M 10.45M n/a 857.57K
Total Liabilities
5.14B 5.04M 4.77M 3.54M 4.68M 5M 5.63M 1.81M 1.22M 1.27M 16.79M 14.42M 12.03M n/a 1.15M
Total Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 12.97M 11.85M 10.45M n/a n/a
Common Stock
1.67M 1.67K 1.67K 1.52K 1.52K 1.46K 1.44K 996.00 996.00 996.00 259.00 259.00 1.48K n/a 259.00
Retained Earnings
-54.14B -48.04M -40.74M -37.82M -33.8M -30.91M -25.86M -27.12M -23.7M -20.61M -17.87M -14.76M -10.74M n/a -5.62M
Comprehensive Income
n/a n/a n/a n/a n/a -149.25K -11.25K n/a -0.00 -0.00 n/a n/a 0.00 -5.15M n/a
Shareholders Equity
28.31B 33.37M 39.58M 32.01M 35.26M 32.54M 35.65M 10.09M 13.25M 16.15M -8.39M -5.36M -1.41M 3.64M 3.64M
Total Investments
n/a n/a 38.3B n/a n/a 149.25K 11.25K n/a n/a n/a n/a n/a n/a 8.68M n/a